Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

The end of the beginning: vaccines for the next 25 years.

Oxford JS.

Vaccine. 2008 Nov 18;26(49):6179-82. doi: 10.1016/j.vaccine.2008.07.106. Epub 2008 Sep 5.

PMID:
18775758
2.

Immunization. Past successes, future challenges.

Grossman M.

Infect Dis Clin North Am. 1995 Jun;9(2):325-33.

PMID:
7673670
3.

[Vaccines, the modern state and societies].

Moulin AM.

Med Sci (Paris). 2007 Apr;23(4):428-34. French.

4.

The history of vaccines and immunization: familiar patterns, new challenges.

Stern AM, Markel H.

Health Aff (Millwood). 2005 May-Jun;24(3):611-21.

PMID:
15886151
5.

A brief history and inventory of immunizations.

Marr JS, Malloy CD.

J Public Health Manag Pract. 1996 Winter;2(1):82-6.

PMID:
10186662
6.
7.

"Vaccine"; 25 years on.

Spier R.

Vaccine. 2008 Nov 18;26(49):6173-6. doi: 10.1016/j.vaccine.2008.07.075. Epub 2008 Aug 13. No abstract available.

PMID:
18706465
8.

Current status and progress of prepandemic and pandemic influenza vaccine development.

Leroux-Roels I, Leroux-Roels G.

Expert Rev Vaccines. 2009 Apr;8(4):401-23. doi: 10.1586/erv.09.15. Review.

PMID:
19348557
9.

200 Jahre Pockenimpfstoff in Deutschland.

Henig EM.

Quellen Stud Gesch Pharm. 1997;73:1-284. German. No abstract available.

PMID:
11636640
10.

Women and vaccinations: From smallpox to the future, a tribute to a partnership benefiting humanity for over 200 years.

Datta SK, Bhatla N, Burgess MA, Lehtinen M, Bock HL.

Hum Vaccin. 2009 Jul;5(7):450-4. Epub 2009 Jul 20. Review.

PMID:
19458487
11.

Vaccine preventable diseases: current perspectives in historical context, Part I.

Weisberg SS.

Dis Mon. 2007 Sep;53(9):422-66. No abstract available.

PMID:
17996745
12.

Vaccine preventable diseases: current perspectives in historical context, Part II.

Weisberg SS.

Dis Mon. 2007 Oct;53(10):467-528. No abstract available.

PMID:
18005790
13.

Vaccinology in practical perspective.

Hilleman MR.

Dev Biol Stand. 1986;63:5-13.

PMID:
3527820
14.

[Influenza vaccine: globalization of public health stakes].

Collin N, Briand S.

Med Trop (Mars). 2009 Aug;69(4):322. French.

PMID:
19725377
15.

Progress with human H5N1 vaccines: a perspective from industry.

Palache B, Krause R.

Expert Rev Vaccines. 2009 Apr;8(4):391-400. doi: 10.1586/erv.09.16. Review.

PMID:
19348556
17.

Immunizations: three centuries of success and ongoing challenges.

Feijó RB, Sáfadi MA.

J Pediatr (Rio J). 2006 Jul;82(3 Suppl):S1-3. No abstract available.

18.

Report of the 5th meeting on the evaluation of pandemic influenza prototype vaccines in clinical trials: World Health Organization, Geneva, Switzerland, 12-13 February 2009.

Hayden FG, Howard WA, Palkonyay L, Kieny MP.

Vaccine. 2009 Jun 24;27(31):4079-89. doi: 10.1016/j.vaccine.2009.04.059. Epub 2009 May 9.

PMID:
19406184
19.

History of vaccines and positioning of current trends.

Payette PJ, Davis HL.

Curr Drug Targets Infect Disord. 2001 Nov;1(3):241-7.

PMID:
12455398
20.

Designer adjuvants for enhancing the efficacy of infectious disease and cancer vaccines based on suppression of regulatory T cell induction.

Mills KH.

Immunol Lett. 2009 Feb 21;122(2):108-11. doi: 10.1016/j.imlet.2008.11.007. Epub 2008 Dec 25. Review.

PMID:
19100777

Supplemental Content

Support Center